Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | IGLV2-18///IGLV3-19///IGL@ |
| Upstream (Parents) |
|---|
| (<<) LOC100134331///LOC100126583///LOC652128///LOC642131///VSIG6///IGHV4-31///IGHM///IGHG4///IGHG3///IGHG1///IGHD///IGHA2///IGHA1///IGH@ → IGLV2-18///IGLV3-19///IGL@ |
| (<<) LOC100126583///IGHV4-31///IGHV@///IGHM///IGHG3///IGHG2///IGHG1///IGHD///IGHA2///IGHA1///IGH@ → IGLV2-18///IGLV3-19///IGL@ |
| (<<) IGLV2-11///IGLV2-18///IGLV2-23///IGLC1///IGL@ → IGLV2-18///IGLV3-19///IGL@ |
| (<<) FAM20B → IGLV2-18///IGLV3-19///IGL@ |
| (<<) IGHV4-31///IGHV@///IGHM///IGHG3///IGHG1///IGHA1 → IGLV2-18///IGLV3-19///IGL@ |
| (<<) IGKV1OR2-118 → IGLV2-18///IGLV3-19///IGL@ |
| Downstream (Children) |
|---|
| IGLV2-18///IGLV3-19///IGL@ → VPS16 (>>) |
| IGLV2-18///IGLV3-19///IGL@ → CCR9 (>>) |
| IGLV2-18///IGLV3-19///IGL@ → MED24 (>>) |
| IGLV2-18///IGLV3-19///IGL@ → PLSCR2 (>>) |
| IGLV2-18///IGLV3-19///IGL@ → CUL3 (>>) |
